JPWO2020247301A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020247301A5 JPWO2020247301A5 JP2021571699A JP2021571699A JPWO2020247301A5 JP WO2020247301 A5 JPWO2020247301 A5 JP WO2020247301A5 JP 2021571699 A JP2021571699 A JP 2021571699A JP 2021571699 A JP2021571699 A JP 2021571699A JP WO2020247301 A5 JPWO2020247301 A5 JP WO2020247301A5
- Authority
- JP
- Japan
- Prior art keywords
- polysaccharide
- protein conjugate
- serotypes
- streptococcus pneumoniae
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000193998 Streptococcus pneumoniae Species 0.000 claims 17
- 229940031000 streptococcus pneumoniae Drugs 0.000 claims 17
- 230000002163 immunogen Effects 0.000 claims 11
- 201000010099 disease Diseases 0.000 claims 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 6
- 208000015181 infectious disease Diseases 0.000 claims 6
- 229960005486 vaccine Drugs 0.000 claims 6
- 108010060123 Conjugate Vaccines Proteins 0.000 claims 5
- 229940031670 conjugate vaccine Drugs 0.000 claims 5
- 238000000034 method Methods 0.000 claims 4
- 238000004519 manufacturing process Methods 0.000 claims 3
- 108090000623 proteins and genes Proteins 0.000 claims 2
- 102000004169 proteins and genes Human genes 0.000 claims 2
- 150000004676 glycans Chemical class 0.000 claims 1
- 229920001282 polysaccharide Polymers 0.000 claims 1
- 239000005017 polysaccharide Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962857534P | 2019-06-05 | 2019-06-05 | |
| US62/857,534 | 2019-06-05 | ||
| PCT/US2020/035511 WO2020247301A1 (en) | 2019-06-05 | 2020-06-01 | Methods of treating patients with an immunogenic composition that protects against s. pneumoniae serotype 29 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022535064A JP2022535064A (ja) | 2022-08-04 |
| JPWO2020247301A5 true JPWO2020247301A5 (enExample) | 2023-06-20 |
Family
ID=73653320
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021571699A Pending JP2022535064A (ja) | 2019-06-05 | 2020-06-01 | 肺炎レンサ球菌血清型２９から保護する免疫原性組成物で患者を治療する方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20220218812A1 (enExample) |
| EP (1) | EP3980050A4 (enExample) |
| JP (1) | JP2022535064A (enExample) |
| KR (1) | KR20220016964A (enExample) |
| CN (1) | CN114025784A (enExample) |
| AU (1) | AU2020289048A1 (enExample) |
| BR (1) | BR112021024491A8 (enExample) |
| CA (1) | CA3142697A1 (enExample) |
| MX (1) | MX2021014948A (enExample) |
| WO (1) | WO2020247301A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20190108583A (ko) | 2017-01-31 | 2019-09-24 | 머크 샤프 앤드 돔 코포레이션 | 다당류-단백질 접합체 제조 방법 |
| CA3050120A1 (en) | 2017-02-24 | 2018-08-30 | Merck Sharp & Dohme Corp. | Enhancing immunogenicity of streptococcus pneumoniae polysaccharide-protein conjugates |
| CN111065387B (zh) | 2017-09-07 | 2023-08-25 | 默沙东有限责任公司 | 肺炎球菌多糖及其在免疫原性多糖-载体蛋白缀合物中的用途 |
| CN111093649B (zh) | 2017-09-07 | 2023-08-25 | 默沙东有限责任公司 | 肺炎球菌多糖及其在免疫原性多糖-载体蛋白缀合物中的用途 |
| US11116828B2 (en) | 2017-12-06 | 2021-09-14 | Merck Sharp & Dohme Corp. | Compositions comprising Streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof |
| WO2019212842A1 (en) | 2018-04-30 | 2019-11-07 | Merck Sharp & Dohme Corp. | Methods for producing streptococcus pneumoniae capsular polysaccharide carrier protein conjugates from lyospheres |
| US11896656B2 (en) | 2018-04-30 | 2024-02-13 | Merck Sharp & Dohme Llc | Methods for providing a homogenous solution of lyophilized mutant diptheria toxin in dimethylsulfoxide |
| US20210252125A1 (en) | 2018-04-30 | 2021-08-19 | Merck Sharp & Dohme Corp. | Methods for producing streptococcus pneumoniae capsular polysaccharide carrier protein conjugates |
| BR112021011961A8 (pt) | 2018-12-19 | 2023-02-07 | Merck Sharp & Dohme | Composições compreendendo conjugados de polissacarídeo-proteína de streptococcus pneumoniae e métodos de uso dos mesmos |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2311976A1 (en) * | 2009-10-19 | 2011-04-20 | Azienda Ospedaliero-Universitaria Meyer | Method for Streptococcus Pneumoniae diagnosis and serotyping |
| TW201136603A (en) * | 2010-02-09 | 2011-11-01 | Merck Sharp & Amp Dohme Corp | 15-valent pneumococcal polysaccharide-protein conjugate vaccine composition |
| US11058757B2 (en) * | 2016-03-31 | 2021-07-13 | Pogona, LLC | Saccharide-polypeptide conjugate compositions and methods of use thereof |
| EP3518965A1 (en) * | 2016-09-30 | 2019-08-07 | Biological E Limited | Multivalent pneumococcal vaccine compositions comprising polysaccharide-protein conjugates |
| MX2019007910A (es) * | 2016-12-30 | 2019-12-05 | Sutrovax Inc | Conjugados de polipeptido-antigeno con aminoacidos no naturales. |
-
2020
- 2020-06-01 MX MX2021014948A patent/MX2021014948A/es unknown
- 2020-06-01 US US17/614,876 patent/US20220218812A1/en not_active Abandoned
- 2020-06-01 CN CN202080049226.4A patent/CN114025784A/zh active Pending
- 2020-06-01 KR KR1020227000140A patent/KR20220016964A/ko not_active Withdrawn
- 2020-06-01 EP EP20819293.0A patent/EP3980050A4/en not_active Withdrawn
- 2020-06-01 CA CA3142697A patent/CA3142697A1/en active Pending
- 2020-06-01 AU AU2020289048A patent/AU2020289048A1/en not_active Abandoned
- 2020-06-01 BR BR112021024491A patent/BR112021024491A8/pt unknown
- 2020-06-01 WO PCT/US2020/035511 patent/WO2020247301A1/en not_active Ceased
- 2020-06-01 JP JP2021571699A patent/JP2022535064A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021505589A5 (enExample) | ||
| PH12022550110A1 (en) | Multivalent pneumococcal polysaccharide-protein conjugate compositions and methods of using the same | |
| PH12020551147A1 (en) | Multivalent pneumococcal polysaccharide-protein conjugate composition | |
| JP2023036953A5 (enExample) | ||
| PH12020551149A1 (en) | Multivalent pneumococcal polysaccharide-protein conjugate composition | |
| HRP20161681T1 (hr) | Cjepivo protiv bakterije streptococcus pneumoniae | |
| JP2025128174A5 (enExample) | ||
| ATE545431T1 (de) | Multivalente pneumokokken-polysaccharid-protein- konjugat-zusammensetzung | |
| TW200719911A (en) | Multivalent pneumococcal polysaccharide-protein conjugate composition | |
| JPWO2020247301A5 (enExample) | ||
| HRP20150587T1 (hr) | Postupak konjugiranja bakterijskog antigena s proteinskim nosaäśem | |
| WO2008079732A3 (en) | Multivalent pneumococcal polysaccharide-protein conjugate composition | |
| HRP20221438T1 (hr) | Postupak glikokonjugiranja | |
| MX336934B (es) | Composicion conjugada polisacarido-proteina neumococica multivalente. | |
| JPWO2021021729A5 (enExample) | ||
| JPWO2019152921A5 (enExample) | ||
| CN108524926B (zh) | 一种多价肺炎球菌结合疫苗的制剂组合及其应用 | |
| JPWO2020058963A5 (enExample) | ||
| RU2021138121A (ru) | Способы лечения пациентов иммуногенной композицией, защищающей от серотипа 29 s. pneumoniae | |
| AR131123A1 (es) | Composiciones inmunógenas que comprenden antígenos de sacárido capsular conjugados y sus usos | |
| NZ775208A (en) | Purified capsular polysaccharides of streptococcus pneumoniae | |
| TH1901000733A (th) | องค์ประกอบคอนจูเกตของมัลติวาเลนท์นิวโมคอคคอลโพลีแซคคาไรด์-โปรตีน | |
| NZ770014B2 (en) | Streptococcus pneumoniae capsular polysaccharides and immunogenic conjugate thereof | |
| RU2020133440A (ru) | КАПСУЛЬНЫЙ ПОЛИСАХАРИД Streptococcus pneumoniae И ЕГО ИММУНОГЕННЫЙ КОНЪЮГАТ |